Wednesday, October 23, 2024

Fw: Ref.: (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 123, October 2024

 

 

Leprosy Mailing List – October 23,  2024

 

Ref.:  (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 123, October 2024

From:  Takahiro Nanri, Tokyo, Japan


 

Dear Dr. Schreuder and Friends,  

 

Warm greetings from Sasakawa Health Foundation/ Sasakawa Leprosy (Hansen's Disease) Initiative in Tokyo.

 

We have issued WHO Goodwill Ambassador's Leprosy Bulletin NO.123 October 2024 "Partnerships make effective action possible."

 

 In this issue, we feature: 

 

MESSAGE FROM THE AMBASSADOR
In September, I visited Nepal for the first time in 10 years. I met with President Ramchandra Paudel and Prime Minister KP Sharma Oli to ask them to reinvigorate leprosy control activities now that the worst of the COVID-19 pandemic has passed.
Read More 

 

50th Anniversary of WHO–TNF/SHF Partnership
Partnerships are the way to create sustainable impact

Dr. Lutz Hegemann, President, Global Health & Sustainability, Novartis

Novartis has been committed to eliminating leprosy for decades, with our multidrug therapy (MDT) as a cornerstone in treating approximately 18 million patients since 1981. Prior to the 1980s, leprosy affected millions of people. Read more 

 

VIEWPOINT
Leading GPZL to new heights in the global fight against Hansen's disease

Dr. Ritu Ghosh, Executive Director, Global Partnership for Zero Leprosy (GPZL)
Hansen's disease, also known as leprosy, is not just a medical condition – it affects every aspect of a person's life. It impacts independence, mobility, and is often linked to deformity, which in turn leads to severe social stigma and discrimination.
Read more 

 

VIEWPOINT
Commentary on WHO's Global leprosy (Hansen disease) update, 2023

Dr. Venkata Ranganadha Rao Pemmaraju, Program Advisor for Medical Issues, Sasakawa Health Foundation

In 2023, 184 out of 221 countries and territories reported on leprosy to the World Health Organization (WHO). Congratulations to all who contributed to the combined efforts of national leprosy programs and WHO for this remarkable achievement. Read more 

 

VIEWPOINT
Strengthening people's organizations should be seen as part of the zero leprosy strategy for Africa

Tesfaye Tadesse Haile, Research Consultant, Sasakawa Health Foundation

Although the world has come a long way towards the elimination of leprosy, we have not reached our goals due to a whirlpool of negligence and poor political and social commitment. Read more 

 

AMBASSADOR'S JOURNAL
Goodwill Ambassador Sasakawa is impressed by Nepal's Self Help Groups in Madhesh Province

From September 16 to 23, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa visited Nepal for the first time in 10 years. Read more 

 

INITIATIVE NEWS
Sasakawa Leprosy Initiative collaborates with Miss Supranational 2024 for leprosy awareness campaign in South Sulawesi, Indonesia

Sasakawa Leprosy (Hansen's Disease) Initiative conducted a series of leprosy awareness activities in South Sulawesi, Indonesia, in partnership with the Miss Supranational 2024 crown holder, Harashta Haifa Zahra, on August 26–27. Read more 

 

BACK ISSUES 

 

We hope that you would enjoy reading the latest Leprosy Bulletin

 

Takahiro NANRI, Ph.D.
President, Sasakawa Health Foundation

*********************************************************
Sasakawa Leprosy (Hansen's Disease) Initiative
Sasakawa Health Foundation
Tel
81-3-6229-5377, Fax81-33-6229-5388
email:
hansen@shf.or.jp


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/83f2256d-bfeb-4c27-a16a-2f3cdaf8f488n%40googlegroups.com.

No comments: